usa-stockpile: massive press-release out !!!

Hello guys,

one of the guys of our German Biota-forum (Marcel aka Massel) was also unsatisfied with the fact, that the important news that the USA move to change their stockpile to 50% Relenza had not been published yet and cannot be found in any media.

Through his business Marcel is connected with PR-agencies.

Marcel has invested effort and money - thats why today the following has happened:

The following news was released as a PRESS-RELEASE today via DOW JONES-NEWSWIRES !
It reaches a large number of finance-media and MORE THAN 120.000 analysts, brokers and employees of banks etc. !!

This is the news that was press-released under Marcels name today:

“USA change stockpile policy
English version:

USA MOVE TO CHANGE ANTIVIRAL-STOCKPILE TO 50% RELENZA

- Meeting National Biodefense Science Board Septemper 25, 2009
Formerly the ratio was 80-20 in favor of Tamiflu and this could also be a signal for other countries to change their stockpiles in favor of Relenza.

Find more information here on pages 178,179 and 180:
http://www.hhs.gov/aspr/conferences/nbsb/nbsb-mtgtrnscrpt-090925.pdf

Quelle / Source: National Biodefense Science Board > NBSB Meetings >
Previous Meetings > September 25, 2009
(http://www.hhs.gov/aspr/omsph/nbsb/meetings/index.html)“
______

When you google “usa change stockpile policy“, you will find the article on page number 1 as number 1.

It was already released on a leading German finance-website http://www.finanznachrichten.de.
A lot of important people in the finance-industry should read these news.
It should spread in the next days.

Unfortunately Massel had been suspended from Hotcopper (like Jerry and some other excellent users), thats why Im posting this.

You find the complete press-release that was released in German and English below.

Best regards from Germany

Eric
_____________________________________

22.10.2009 14:24
RELEASE-NET /USA change stockpile policy - USA ändern Tamiflu / Relenza-Medikamentenverhältnis

DJ RELEASE-NET /USA change stockpile policy - USA ändern Tamiflu / Relenza-Medikamentenverhältnis


USA change stockpile policy - USA ändern Tamiflu /
Relenza-Medikamentenverhältnis

Die US-Regierung, im Speziellen das Meeting National Biodefense Science
Board, hat jüngsten Informationen zufolge mit einer Entscheidung vom
25.9.2009 ihre Stockpile-Politik geändert. Danach wird das ehemalige Tamiflu
/ Relenza-Medikamentenverhältnis von 80:20 in 50:50 umgeschichtet.

Diese Umschichtung könnte eine Signalwirkung für andere Länder haben, ihren
Stockpile ebenfalls zugunsten von Relenza umzuschichten.

So heißt es in dem 383 Seiten starken Bericht des Meeting National
Biodefense Science Board vom 25.09.2009 - abrufbar unter
http://www.hhs.gov/aspr/conferences/nbsb/nbsb-mtgtrnscrpt-090925.pdf - auf
den Seiten 178 ff.:

... \"Because of that we moved to change the policy from an 80-20 ratio to a
50-50, because we had not seen significant resistance to the zanamivir
product Relenza. However, when we bought antivirals, the first one was still
an 80-20. As we\'ve gone on through the summer that has been delivered. And
so the federal stockpile has been replenished.\'\'...

...\"As we\'ve gone forward the secretary signed a memo recommended by the
agencies within the department to buy more based on the actions we had
before. And that was that we needed to move forward with a more balanced or
50-50 ratio of these two drugs. So we will be going out soon with purchases
of more zanamivir\"...

English version:

USA MOVE TO CHANGE ANTIVIRAL-STOCKPILE TO 50% RELENZA

- Meeting National Biodefense Science Board Septemper 25, 2009
Formerly the ratio was 80-20 in favor of Tamiflu and this could also be a
signal for other countries to change their stockpiles in favor of Relenza.

Find more information here on pages 178,179 and 180:

http://www.hhs.gov/aspr/conferences/nbsb/nbsb-mtgtrnscrpt-090925.pdf

Quelle / Source: National Biodefense Science Board > NBSB Meetings >
Previous Meetings > September 25, 2009
(http://www.hhs.gov/aspr/omsph/nbsb/meetings/index.html)

=---------------------------------------------------------------------------
Marcel Suffrian

Herderstr. 86
40721 Hilden
Tel.0172-5188198
=---------------------------------------------------------------------------

Der Artikel unterliegt dem geistigen Eigentum des Autors.

Die Weitergabe bzw. die Veröffentlichung an Dritte (auch auszugsweise) ist
ohne Zustimmung des Autors nicht gestattet.

Hinweis:

Alle Informationen und Daten aus dieser Nachricht stammen aus Quellen, die
der Autor zum Zeitpunkt der Erstellung für zuverlässig und vertrauenswürdig
hält. Der Autor hat die größtmögliche Sorgfalt darauf verwandt,
sicherzustellen, dass die verwendeten und zugrunde liegenden Daten und
Tatsachen vollständig und zutreffend sind. Trotzdem übernimmt der Autor
keine Gewähr oder Haftung für die Richtigkeit, Genauigkeit und
Vollständigkeit der verwendeten und zugrunde liegenden Daten und Tatsachen.
Diese Mitteilung wurde übermittelt von RELEASE-NET. Für den Inhalt ist
ausschließlich der unter Presse-Kontakt genannte Herausgeber der Mitteilung
verantwortlich.


(END) Dow Jones Newswires

October 22, 2009 07:53 ET (11:53 GMT)